M
Maria Antonietta Gambacorta
Researcher at Catholic University of the Sacred Heart
Publications - 236
Citations - 5291
Maria Antonietta Gambacorta is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Medicine & Radiation therapy. The author has an hindex of 33, co-authored 162 publications receiving 4141 citations. Previous affiliations of Maria Antonietta Gambacorta include The Catholic University of America & Agostino Gemelli University Polyclinic.
Papers
More filters
Journal ArticleDOI
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
Vincenzo Valentini,Ruud G.P.M. van Stiphout,Guido Lammering,Maria Antonietta Gambacorta,M.C. Barba,Marek Bębenek,Franck Bonnetain,Jean François Bosset,Krzysztof Bujko,Luca Cionini,Jean Pierre Gerard,Claus Rödel,Aldo Sainato,Rolf Sauer,Bruce D. Minsky,Laurence Collette,Philippe Lambin +16 more
TL;DR: The easy-to-use nomograms can predict LR, DM, and OS over a 5-year period after surgery and may be used as decision support tools in future trials by using the three defined risk groups to select patients for postoperative chemotherapy and close follow-up.
Journal ArticleDOI
Prognostic Value of Pathologic Complete Response After Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Long-Term Analysis of 566 ypCR Patients
Carlo Capirci,Vincenzo Valentini,Luca Cionini,Antonino De Paoli,Claus Rödel,Rob Glynne-Jones,Claudio Coco,Mario R. Romano,Giovanna Mantello,Silvia Palazzi,Falchetti Osti Mattia,Maria Luisa Friso,Domenico Genovesi,C. Vidali,Maria Antonietta Gambacorta,Alberto Buffoli,Marco Lupattelli,Maria Silvia Favretto,Giuseppe La Torre +18 more
TL;DR: A ypCR after neoadjuvant therapy identified a favorable group of patients, even in this large series of 566 patients collected in 61 centers, to verify whether yp CR predicts a favorable outcome in a largeseries of patients.
Journal ArticleDOI
The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
Fabio Maria Vecchio,Vincenzo Valentini,Bruce D. Minsky,Gilbert D.A. Padula,Ennapadam Venkatraman,Mario Balducci,Francesco Miccichè,Riccardo Ricci,Alessio G. Morganti,Maria Antonietta Gambacorta,Francesca Maurizi,Claudio Coco +11 more
TL;DR: By univariate analysis, TRG is a predictor for local failure, metastases-free survival, and overall survival and by multivariateAnalysis, it predicts improved disease- free survival.
Journal ArticleDOI
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum
Cornelis J.H. van de Velde,Petra G. Boelens,Josep M. Borràs,Jan Willem Coebergh,Andrés Cervantes,Lennart Blomqvist,Regina G. H. Beets-Tan,Colette B.M. van den Broek,Gina Brown,Eric Van Cutsem,Eloy Espin,Karin Haustermans,Bengt Glimelius,Lene Hjerrild Iversen,J. Han van Krieken,Corrie A.M. Marijnen,Geoffrey Henning,Jola Gore-Booth,E. Meldolesi,Pawel Mroczkowski,Iris D. Nagtegaal,Peter Naredi,H. Ortiz,Lars Påhlman,Philip Quirke,Claus Rödel,Arnaud Roth,Harm J. T. Rutten,Hans J. Schmoll,J. J. Smith,Pieter J. Tanis,Claire Taylor,A. Wibe,Theo Wiggers,Maria Antonietta Gambacorta,Cynthia Aristei,Vincenzo Valentini +36 more
TL;DR: The first multidisciplinary consensus conference about cancer of the colon and rectum was held in December 2012 as mentioned in this paper, where the expert panel consisted of representatives of European scientific organisations involved in cancer care of patients with colon and Rectal cancer and representatives of national colorectal registries.
Journal ArticleDOI
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy.
Brunella Barbaro,Cecilia Fiorucci,Carmela Tebala,Vincenzo Valentini,Maria Antonietta Gambacorta,Fabio Maria Vecchio,Gianluca Rizzo,Claudio Coco,Antonio Crucitti,Carlo Ratto,Lorenzo Bonomo +10 more
TL;DR: After CRT, morphologic and volumetric evaluation at MR imaging had a high PPV and a low NPV for response assessment, and the detection of small clusters of residual tumor cells within fibrosis remains a problem.